Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension

Journal of Cardiology

Volumn 27, Issue 4, 1996, Pages 197-205

  Saji, T ^a   Ozawa, Y ^a   Nakayama, T ^a   Matsuura, H ^a   Hashiguchi, R ^a   Matsuo, N ^a   Muto, H ^a   Yamazaki, J I ^a   Morishita, T ^a   Saito, T ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

drug administration (beraprost); prostacyclin; pulmonary hypertension (primary, secondary)

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; DIGOXIN; DILTIAZEM; DORNAR; ENALAPRIL; FUROSEMIDE; ISOSORBIDE DINITRATE; OZAGREL; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SPIRONOLACTONE; THROMBOXANE B2; UNCLASSIFIED DRUG; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HEADACHE; HEART INDEX; HEMODYNAMICS; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PULMONARY HYPERTENSION; SCHOOL CHILD; TREATMENT OUTCOME; VASODILATATION; VOMITING;

6-KETOPROSTAGLANDIN F1 ALPHA; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE; THROMBOXANE B2; TIME FACTORS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0029887147     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)